Report Back From ASCO 2024: What’s the Latest in HR+ MBC?
Living with MBC, Diagnosis and Treatment, Clinical Research, Research, ASCO Our MBClife Living with MBC, Diagnosis and Treatment, Clinical Research, Research, ASCO Our MBClife

Report Back From ASCO 2024: What’s the Latest in HR+ MBC?

We are thrilled to present an audio version of SHARE Cancer Support’s webinar “Report Back from ASCO 2024: Latest Updates on HR+ Metastatic Breast Cancer (MBC)”.

This episode is an in-depth report from the ASCO 2024 Annual Meeting, featuring the latest advancements and research in HR+ MBC. Hear from Dr. Kevin Kalinsky as we dive into the findings from the DESTINY-Breast06 and postMONARCH trials, exploring their implications and potential impact on treatment strategies.

Read More
Dr. Shanu Modi: How to Get a Standing Ovation at ASCO?
Entities of Cancer, Difficult to Treat, Novel Treatments, Medical Community, Clinical Research, Updates from Conferences Our MBClife Entities of Cancer, Difficult to Treat, Novel Treatments, Medical Community, Clinical Research, Updates from Conferences Our MBClife

Dr. Shanu Modi: How to Get a Standing Ovation at ASCO?

MSK’s Dr. Shanu Modi, lead investigator on the DESTINY-Breast04 trial, talks with the Our MBC Life team about the trial’s standing ovation at ASCO, how to know if we’re HER2-low, and what this all means for us.

Read More